Spain · Advertising framework
Online video advertising for OTC medicines in Spain
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Eligible non-prescription ads remain subject to detailed content rules
Legal requirement — paraphrased
Confirm all public-advertising eligibility conditions. Include the applicable identification, correct-use information and instructions to read the leaflet and consult the pharmacist. Consumer non-prescription medicine ads do not generally need prior administrative authorisation, but remain subject to supervision. Review promotional gifts and incentives separately.
Sources: RDL 1/2015: guarantees and rational use of medicines and health products
Exclude prohibited endorsements and purchase incentives
Legal requirement — paraphrased
Article 80(2) excludes cure assurances and testimonials about product virtues, including professional or celebrity testimonials that induce consumption. Regulatory authorisation cannot be used as the advertising argument.
Article 80(5) prohibits premiums, gifts, prizes, competitions, bonuses and similar inducements linked to public promotion or sale of these medicines. Assess ordinary pharmacy price reductions separately rather than equating every price reduction with a permitted advertising incentive.
Sources: RDL 1/2015: guarantees and rational use of medicines and health products · RDL 1/2015 Article 80(2)(d)–(e), 80(5), and additional provision eight
Channel rules
Check the complete consumer-facing message
Regulator guidance
The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.
Sources: EU Unfair Commercial Practices Directive 2005/29/EC
Identify the advertisement and advertiser
Regulator guidance
LSSI guidance requires online commercial communications to be recognisable as advertising and identify the advertiser. This applies alongside health-sector restrictions; a label does not authorise a prohibited health claim.
Sources: LSSI: Publicidad en Internet
Review personal data separately from the advertisement
Legal requirement — paraphrased
Identify an Article 6 basis for personal-data processing and an applicable Article 9 condition for health data. Provide appropriate transparency and honour the right to object to direct marketing. Permission to deliver healthcare does not automatically authorise advertising use of patient data; electronic contact and trackers also need their own local review.
Approve the final audiovisual edit
Editorial recommendation
Review speech, captions, demonstrations, overlay visibility and playback speed. Recheck short edits and silent versions against applicable product warning and disclosure requirements.
Campaign workflow
OTC Medicines: prepare the review
Editorial recommendation
Confirm the exact product qualifies for consumer advertising in this country. Match each indication, dosage and safety statement to the current local product information. Obtain the applicable warning wording and format rules before buying space.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Confirm the exact product qualifies for consumer advertising in this country.
- Match each indication, dosage and safety statement to the current local product information.
- Obtain the applicable warning wording and format rules before buying space.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Retained IVD advertising rules, Madrid device-ad approval and provider registration-number requirements are documented. Determine the actual autonomous community before filing; other regional procedures, profession-specific codes and the exact promotion remain to be checked.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
For OTC medicines in online videos in Spain, confirm the advertising status of the exact product. This framework connects the locally permitted uses with the information, warnings and execution checks relevant to the selected channel.
A video combines sound, images, captions and timing. Review the full edit and each short-form excerpt, allowing for the relevant warning or disclosure presentation and the possibility that a silent version needs a separate format assessment.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. Spanish national health-advertising baseline plus EU requirements; autonomous-community rules remain relevant. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- RDL 1/2015: guarantees and rational use of medicines and health products
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU Unfair Commercial Practices Directive 2005/29/EC
EU framework implemented through national law; sector rules and local implementation also apply.
- LSSI: Publicidad en Internet
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU General Data Protection Regulation 2016/679
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
From framework to action
Local expertise in Spain
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in Spain.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.